RD1 |
Mechanisms, diagnostics and monitoring of socially significant diseases (neurodegenerative, cardiovascular, oncological and rare diseases)Read more...Development of methods for diagnosis and monitoring of various diseases and identification of biomarkers, applying a thermodynamic approach for the study of complex biological fluids (blood plasma / serum) and intact (blood, tumor and non-tumorigenic) cells; investigation of the role of membrane lipid molecules and their functionally active metabolites in the genesis and development of pathological cellular conditions; lateral organization of membrane lipids, membrane phospholipid asymmetry; role of fatty acids and phospholipids in cellular aging processes; assessment of the dynamics of specialized membrane domains in order to reveal the molecular mechanisms of action of membrane-related and other pathologies; studies for identification of new biomarkers for oncological diseases; development of different model systems to test new hypotheses, uncovering molecular interactions and new mechanisms of action at the cellular level; in silico modelling of new compounds (selective or multi-targeting ligands) with optimized pharmacokinetic properties suitable for preclinical studies. |
Laboratories: ① ② ③ ④ ⑤ ⑥ ⑦ ⑧ ⑨ ⑩ |
RD2 |
Cell signaling and cell behaviorRead more...Electroporation, electrofusion, electrotransformation, macromolecule transmission through membranes, tumour electrochemotherapy; cell adhesion and reorganization of the cytoskeleton after electrotreatment, adhesive properties to nanostructures under the influence of an electric field; mechanisms of interaction of nanomaterials with cellular components, cyto- and genotoxicity; analysis of synthetic and natural substances with anti-oxidant and anti-tumour action; studying the mechanisms of interaction of ligand-receptor pairs; protein-protein interaction; tracking and characterization of signaling cascades; effects on cellular lipid metabolism; transmembrane signal transmission; morphological and nanomechanical properties of plasma / cell membranes; aging of erythrocytes. |
Laboratories: ① ④ ⑥ ⑦ ⑧ ⑨ |
RD3 |
Structural and functional characterization of biomolecular layersRead more...Experimental and theoretical studies of lipid membrane structures aiming to describe the molecular mechanisms of interaction with pore-forming peptides, amphiphilic and lipophilic molecules and biomolecular complexes with potential to be applied in biomedicine; Determination of mechanical and electrical properties of model membrane systems by electrochemical impedance spectroscopy, fluctuation analysis and electroporation; Rheological studies on biomimetic membrane systems and cells oriented toward hemopathologies; Investigation of the interaction between electromagnetic fields and biological matter for the application of electromagnetic echo-effect (EMEE) and development of innovative sensors based on it. |
Laboratories: ① ② ③ ④ ⑤ ⑥ |
RD4 |
Molecular modelling and molecular dynamics, screening, design and synthesis of protein ligandsRead more...Application of QSAR (quantitative structure-activity dependencies) and molecular modelling approaches to characterize the relationship between the structure of compounds and their biological effect; synthesis of amino acids, peptides and peptidomimetics with improved drug-like properties; synthesis of molecular probes and prodrugs; assessment of the toxic effects of chemicals on the human health; modelling of complex biological systems such as myelinated axon or surface electromyography signal. |
Laboratories: ① ③ ⑦ ⑧ ⑨ |
RD5 |
Mathematical modellingRead more...Further elaboration of theories of generalized networks and of intuitionistic fuzzy sets and their application in medicine and biology; use of modern information technologies and development of intelligent systems to support the diagnostic and therapeutic process in practical healthcare; modelling of pathological processes, patients’ databases, formalization of knowledge for making diagnostic and therapeutic decision; development of health screening and monitoring systems; application of modern systems analysis approaches, engineering-mathematical and computer-oriented methods and tools for information technologies support, analysis, modelling, optimization and management of systems related to the development of products for pharmaceutical, food and other industries. |
Laboratories: ③ ⑩ ⑪ ⑫ |
RD6 |
Bioinformatics and bioengineeringRead more...Development of software and hardware for processing and analysis of biomedical signals and data: improvement of existing and introduction of new diagnostic and therapeutic practices in clinical medicine, including those based on artificial intelligence methods (decision rules, self-training expert systems); development of automatic devices for adequate and immediate response in critical life-threatening situations; development of telemetric medical communication facilities; development of clinical practice tools and devices for testing the compliance of clinical and ambulatory equipment with the European and national metrological standards. |
Laboratories: ⑩ ⑪ ⑫ |
Hits: 133